CG Oncology CGON
NASDAQ CGON
$67.38 -0.97 (-1.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

CG Oncology (CGON) Depreciation and Depletion (2024 - 2026)

Updated

CG Oncology's Depreciation and Depletion came in at $900,000 for Q2 2026, up 12.5% from the prior quarter.

Analysis

CG Oncology (CGON) Depreciation and Depletion (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, CG Oncology reported Depreciation and Depletion of $3 million; for FY2025, it came in at $1.4 million.

  • Going back by year, Depreciation and Depletion was $100,000 in FY2024 (unchanged) and $100,000 in FY2023.
  • Business Quant data shows CGON's Depreciation and Depletion at $800,000 (Q1 2026), $800,000 (Q4 2025) and $500,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 CG Oncology 6.04 Bn 6.04 Bn -2.77 Mn 900,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 900,000.00
Mar 31, 2026 800,000.00
Dec 31, 2025 800,000.00
Sep 30, 2025 500,000.00
Mar 31, 2025 100,000.00
Sep 30, 2024 100,000.00
API Access

CG Oncology Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=CGON&period=max&api_key=YOUR_API_KEY